Black Diamond Therapeutics Director Rajeev Shah Purchased 935,850 Shares @ Avg Price Of $5.00/Share As Reported In Form 4 Filing
Portfolio Pulse from Charles Gross
Rajeev Shah, a director at Black Diamond Therapeutics, has purchased 935,850 shares at an average price of $5.00 per share, as reported in a Form 4 filing.
July 07, 2023 | 8:46 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Director Rajeev Shah's purchase of 935,850 shares at $5.00 each indicates a strong belief in the company's future performance.
Insider buying, especially of this magnitude, is often seen as a positive sign by investors as it indicates that those with the most insight into the company believe in its future performance. This could potentially lead to increased investor confidence and a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100